Evidence map›Paper›PMID 34477806›Full record

ArticleThe Journal of experimental medicine2021

Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation.

Yael Goldfarb, Tal Givony, Noam Kadouri, Jan Dobeš, Cristina Peligero-Cruz, Itay Zalayat, Golda Damari, Bareket Dassa, Shifra Ben-Dor, Yael Gruper and 15 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Systematic and proactive evaluation of AIRE missense variant effects.bioRxiv : the preprint server for biology · 2025
    Article
  8. A novel heterozygous pathogenicJournal of human immunity · 2025
    Article
  9. Article
  10. Article
  11. Aire Mutations and Autoimmune Diseases.Advances in experimental medicine and biology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Insm1 regulates mTEC development and immune tolerance.Cellular & molecular immunology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 5 countries.

Yael GoldfarbDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-9472-9577
Tal GivonyDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-0568-8049
Noam KadouriDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-2978-4318
Jan DobešDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-1853-1603
Cristina Peligero-CruzDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-7465-5008
Itay ZalayatDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-5988-0044
Golda DamariDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-5451-0378
Bareket DassaBioinformatics Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-5226-7554
Shifra Ben-DorBioinformatics Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-9604-1939
Yael GruperDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-7912-2243
Bergithe E OftedalDepartment of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.ORCID 0000-0003-4248-7737
Eirik BratlandDepartment of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.ORCID 0000-0002-8359-9818
Martina M ErichsenDepartment of Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.ORCID 0000-0001-9815-972X
Amund BergerDepartment of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.ORCID 0000-0001-6973-2048
Ayelet AvinDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3321-5190
Shir NevoDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-1345-6301
Uku HaljasorgDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-1541-6020
Yael KupermanDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3830-1856
Adi UlmanDepartment of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-3175-5006
Rebecca Haffner-KrauszDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0001-6503-7646
Ziv PoratFlow Cytometry Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0003-3059-181X
Ulus AtasoyDivision of Allergy and Immunology, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-4095-1359
Dena LeshkowitzBioinformatics Unit, Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-4703-2830
Eystein S Husebye *Department of Clinical Science and K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Bergen, Norway.ORCID 0000-0002-7886-2976
Jakub Abramson *Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.ORCID 0000-0002-1745-8996
Weizmann Institute of Science · ILUniversity of Bergen · NOHaraldsplass Diakonale Sykehus · NOHaukeland University Hospital · NOUniversity of Michigan · US

Funding

European Research Council ERC-2016-CoG-724821
6 · The paper itself

Abstract

The autoimmune regulator (AIRE) is essential for the establishment of central tolerance and prevention of autoimmunity. Interestingly, different AIRE mutations cause autoimmunity in either recessive or dominant-negative manners. Using engineered mouse models, we establish that some monoallelic mutants, including C311Y and C446G, cause breakdown of central tolerance. By using RNAseq, ATACseq, ChIPseq, and protein analyses, we dissect the underlying mechanisms for their dominancy. Specifically, we show that recessive mutations result in a lack of AIRE protein expression, while the dominant mutations in both PHD domains augment the expression of dysfunctional AIRE with altered capacity to bind chromatin and induce gene expression. Finally, we demonstrate that enhanced AIRE expression is partially due to increased chromatin accessibility of the AIRE proximal enhancer, which serves as a docking site for AIRE binding. Therefore, our data not only elucidate why some AIRE mutations are recessive while others dominant, but also identify an autoregulatory mechanism by which AIRE negatively modulates its own expression.

Indexed as

AIRE ProteinAnimalsAutoimmunityChromatinDissectionFemaleHomeostasisHumansMaleMiceMice, Inbred C57BLMice, Inbred NODModels, AnimalMutationTranscription FactorsAIRE ProteinChromatinTranscription Factors

Identifiers

PMID34477806
PMCPMC8421262
OpenAlexW3197663761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.